- 2023Biochemical Society transactions10.1042/BST20230018
The role of peroxidasin in solid cancer progression.
- 2023Nature cancer10.1038/s43018-023-00614-y
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
- 2022Nature communications10.1038/s41467-022-32255-7
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis.
Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours.